PH31439A - Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. - Google Patents

Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.

Info

Publication number
PH31439A
PH31439A PH49098A PH49098A PH31439A PH 31439 A PH31439 A PH 31439A PH 49098 A PH49098 A PH 49098A PH 49098 A PH49098 A PH 49098A PH 31439 A PH31439 A PH 31439A
Authority
PH
Philippines
Prior art keywords
cholecalciferol
ene
dihydroxy
stable
active metabolites
Prior art date
Application number
PH49098A
Other languages
English (en)
Inventor
Mclane John Arthur
Satyanarayama G Reddy
Milar R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH31439A publication Critical patent/PH31439A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH49098A 1993-10-01 1994-09-30 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. PH31439A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/131,264 US5401733A (en) 1993-10-01 1993-10-01 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol

Publications (1)

Publication Number Publication Date
PH31439A true PH31439A (en) 1998-11-03

Family

ID=22448675

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49098A PH31439A (en) 1993-10-01 1994-09-30 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.

Country Status (15)

Country Link
US (1) US5401733A (da)
EP (1) EP0646576B1 (da)
JP (1) JP2677520B2 (da)
CN (1) CN1041201C (da)
AT (1) ATE162786T1 (da)
AU (1) AU683917B2 (da)
CA (1) CA2133144C (da)
DE (1) DE69408244T2 (da)
DK (1) DK0646576T3 (da)
ES (1) ES2113020T3 (da)
GR (1) GR3026154T3 (da)
NZ (1) NZ264537A (da)
PH (1) PH31439A (da)
RU (1) RU2133738C1 (da)
ZA (1) ZA947453B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
CA2275382A1 (en) * 1996-12-20 1998-07-02 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin d derivatives
DE69813380T2 (de) * 1997-05-02 2003-12-04 Duphar International Research B.V., Weesp Verfahren zur Herstellung von 16-Dehydro Vitamin D Verbindungen
AU743514B2 (en) * 1997-05-16 2002-01-24 Women & Infants Hospital Cyclic ether vitamin D3 compounds, 1alpha (OH) 3-EPI-vitamin D3 compounds and uses thereof
WO1998051664A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
AU9376998A (en) * 1997-09-02 1999-03-22 Johns Hopkins University School Of Medicine, The Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
US4495181A (en) * 1983-10-03 1985-01-22 The Regents Of The University Of California 1,25-Dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd １α．２５−ジヒドロキシ−２６．２７−ジメチルビタミンＤ↓３
JPS61129130A (ja) * 1984-11-27 1986-06-17 Kureha Chem Ind Co Ltd 抗尿毒症剤
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
EP0205285B1 (en) * 1985-05-30 1989-08-09 Taisho Pharmaceutical Co. Ltd Vitamin d3 derivatives
US4832875A (en) * 1985-11-21 1989-05-23 Taisho Pharmaceutical Co., Ltd. Vitamin D3 derivative
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Also Published As

Publication number Publication date
GR3026154T3 (en) 1998-05-29
AU683917B2 (en) 1997-11-27
DE69408244D1 (de) 1998-03-05
CA2133144C (en) 2005-05-24
CN1106384A (zh) 1995-08-09
NZ264537A (en) 1996-05-28
EP0646576B1 (en) 1998-01-28
EP0646576A1 (en) 1995-04-05
ATE162786T1 (de) 1998-02-15
JP2677520B2 (ja) 1997-11-17
RU94035663A (ru) 1996-07-20
US5401733A (en) 1995-03-28
CA2133144A1 (en) 1995-04-02
ZA947453B (en) 1995-04-03
CN1041201C (zh) 1998-12-16
RU2133738C1 (ru) 1999-07-27
DE69408244T2 (de) 1998-08-27
AU7422594A (en) 1995-04-13
DK0646576T3 (da) 1998-09-23
JPH07179418A (ja) 1995-07-18
ES2113020T3 (es) 1998-04-16

Similar Documents

Publication Publication Date Title
ES2062334T3 (es) Compuestos de 19-nor-vitamina d.
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
EG18334A (en) Pyrozoline compounds and their use as pesticides
HU9601103D0 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
PH31439A (en) Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.
GB8828694D0 (en) Preparation for introducing active substance for regulating tanning into skin production & use thereof
HK1042038A1 (zh) 用於促進神經細胞分化的含有環狀甘油磷酯及其類似物的藥物組合物
BG101126A (en) The use of muramylpeptide compounds
IL114520A0 (en) Dinucleoside-5',5',-pyrophosphates
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ES8302634A1 (es) Procedimiento de preparacion de derivados del acido metilen-2-succinamico
GR75239B (da)
IL57609A (en) Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids
EP0551844A3 (da)
IE830308L (en) Selective herbicidals
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
MX9703492A (es) Regulacion de proliferacion de celulas germinales neurales.
SU1086720A1 (ru) 1,1,1-трихлор-2-окси-4-(4-нитрофенил)бутанон-4 в качестве промежуточного продукта в синтезе 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-она-4 и 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-он-4 в качестве фунгицида
GR3024709T3 (en) Novel cytarabine derivatives, their production and use